News & Perspective

Dec 21, 2001

Dec 21, 2001

FDA completes inspection of anthrax vaccine plant; company expects approval

Dec 4, 2003 (CIDRAP News) – Thousands of US Customs and Border Protection (CBP) officers will help the Food and Drug Administration (FDA) inspect imported food under an agreement signed yesterday, according to the FDA.

Dec 21, 2001

Congress approves $2.5 billion for bioterrorism preparedness

(CIDRAP News) – In a flurry of pre-adjournment activity yesterday, Congress appropriated about $2.5 billion for bioterrorism preparedness, including $1 billion for state and local efforts, according to an aide to Sen. Bill Frist, R-Tenn.

Dec 13, 2001

Dec 13, 2001

House passes $2.9 billion authorization for bioterrorism preparedness

(CIDRAP News) – The US House of Representatives on Wednesday overwhelmingly approved a bill authorizing about $2.9 billion in spending on preparedness for bioterrorism and other public health emergencies.

Dec 13, 2001

Dec 13, 2001

Finding an antitoxin is among priorities for anthrax research

(CIDRAP News) – The Centers for Disease Control and Prevention's (CDC's) priorities for research on anthrax include development of an antitoxin, aerosolization of anthrax powders sent by mail, and postexposure prophylaxis, CDC officials said this week.

Dec 10, 2001

Dec 10, 2001

HHS announces new bioterrorism research initiatives

(CIDRAP News) – The US Department of Health and Human Services (HHS) has announced seven new research grant programs to speed efforts to prevent, diagnose, and treat diseases related to bioterrorism.

Dec 06, 2001

Dec 06, 2001

85 million mail items processed at anthrax-contaminated facilities, CDC reports

(CIDRAP News) – Eighty-five million pieces of mail were processed at anthrax-contaminated Postal Service plants in New Jersey and Washington, DC, before the plants were closed, the Centers for Disease Control and Prevented (CDC) reported today. Although the numbers suggest that cross-contaminated mail may be widespread, officials said the risk of contracting inhalational anthrax from such mail is very low.

Dec 05, 2001

Dec 05, 2001

Quarantine not likely to be best tool for halting bioterrorism-related disease, experts say

(CIDRAP News) – Large-scale quarantine of potentially exposed people is not likely to be the optimal strategy for containing a disease outbreak resulting from bioterrorism in most circumstances, according to public health experts writing in today's issue of the Journal of the American Medical Association.

Nov 30, 2001

Nov 30, 2001

Ciprofloxacin side effects ranged up to 19% in postal workers

(CIDRAP News) – About 19% of more than 3,000 postal workers who took ciprofloxacin to prevent anthrax from the recent bioterrorist attacks reported having "severe" gastrointestinal side effects, but only 2% sought medical attention for them, according to the Centers for Disease Control and Prevention (CDC). Officials described the findings as being in line with other reports on ciprofloxacin.

Nov 27, 2001

Nov 27, 2001

CDC smallpox plan favors focused vaccination program over mass campaign

(CIDRAP News) – If smallpox reappears in the United States, health authorities will strive to trace and vaccinate everyone who has had contact with infected or exposed persons but probably will not mount any mass vaccination campaigns, according to a draft plan released Monday by the Centers for Disease Control and Prevention (CDC).

Nov 19, 2001

Nov 19, 2001

CDC seeks to determine natural background level of anthrax

Nov 16, 2001 (CIDRAP News) – In the current investigation of anthrax cases, the Centers for Disease Control and Prevention (CDC) will try to determine if some parts of the country have a normal background level of anthrax spores that poses no threat to humans and, if so, what that level is, CDC officials said today.

Pages

Sort Results

 

Narrow results

Newsletter Sign-up

Get CIDRAP news and other free newsletters.

Sign up now»

OUR UNDERWRITERS

Unrestricted financial support provided by

Bentson Foundation 3M Gilead 
Grant support for ASP provided by

  Become an underwriter»